The International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs gathers leading experts to discuss all aspects of the optimal use of antiviral therapy including drug-drug interactions, pharmacokinetics of investigational and existing drugs, pharmacodynamics, drug dosing in underrepresented populations, post-marketing surveillance, and regulatory considerations.
Poster
Population pharmacokinetics of ravidasvir in HCV (+/- HIV) chronically infected adults with no or compensated cirrhosis in Thailand and Malaysia Panjasawatwong N, Menétrey C, Ribeiro I, Salvadori N, Swanson A, Tan SS, Thanprasertsuk S, Thongsawat S, Cressey TR, and the STORM-C-1 study team |